Breaking News and Information-SNPK Good evening,
I would like to thank hotinfo for the opportunity to enlighten him on the business process and how data collection and referencing is imperial. The correct term hotinfo is trying to excerpt is "Caveat Emptor" and I stand 100% for investors doing due diligence, risk tolerance analysis, fundamental analysis, and of course in the otcbb-technical analysis. Investors must strive to gather as much information on their investments as possible. That is why I reference my material and figures so that they are indeed credible and not a mouth full of diarrhea blabber.
In light of todays technical analysis we find that SNPK broke through the resistance of $1.54 up to $1.57. Although it did not close at the high of the day, the support levels remained above $1.53 which was the opening value. This indicates that the buyers controlled the market and upheld the price despite any negative misguidance promoted by hotinfo. Too bad for your short position :)
As you all might have read this evening, Sunpeaks Ventures has announced yet another strategic business opportunity by reaching an agreement to further their sales base in yet another continent. They have reached an agreement to expand their sales base into the UK which now gives them 4 continents (NA, EU, RS, AS) as well as considerable exposure online. This product, despite the nay-sayers theory, is well received around the globe as it is an untouched industry-now placated by a single patented product-Clotamin.
This is the best possible scenario for Sunpeaks as Harvard Business School clearly teaches that it is better to create a new industry than to compete among existing counterparts of the economy. How companies gain the financial capacity to fill that need-by means of production, distribution, and administration-is through an IPO. If you invest at all without the use of a financial advisor (strongly not recommended), then you must know that every company must start somewhere by gaining capital through the sale of stock so that they may continue these duties. "When consumers cry out for a need to be filled it is industry's duty to fill that need and to capitalize on its intellectual property such that competition is eliminated for the duration of the patent pursued." At an early stage every IPO, be it Microsoft to McDonalds, must start at price x, and if merited, will inflate to price y. This is how companies build the capital they need to do business and is natural of all IPO's worth buying.
This is common knowledge and to freak out about an IPO going up when they have a great product, growth in sales channels, contractual global expansion, and an excellent advertising campaign, is ridiculous! Everyone please rely only on sound research, do your own additional research, and of course...
Please see these reputable reference links below for validated information:
https://finance.yahoo.com/news/sunpeaks-ventures-enters-agreement-uk-212800655.html
https://thestockmarketwatch.com/newsletters/2012/04/12/breaking-snpk-enters-agreement-to-introduce-clotamin-to-uk-and/
https://stockreads.com/Stock-Newsletter.aspx?id=58506
https://legalnews.findlaw.com/article/03EBeHj3VAdpY?q=European+Union
So don't take my word for it, look for yourself. I need not pump up any company which has genuine potential. The proof is in the pudding as it were and hotinfo, you were proven wrong when the stock continued to climb despite your pile of cow manure. Moreover, it will continue to climb tomorrow as buying pressure will likely push the price up due to the recent expansion news. This company will not stop. It will climb and climb and climb. The truth hurts hotinfo and to quote a famous law cliche, "the facts is facts."
Good night everyone and God bless.
The Goldman Bull. - Negativity is a product of insecurity.